CALX CALIX NETWORKS
Consumer Discretionary · Russell 2000
Next earnings: Mon 25 Jan 2027 · estimated
What 9 analyst firms say about CALIX NETWORKS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
8 rated views · 9 analyst/firm records · 9 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8059
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8042
Recent analyst activity · last 90 days
Our tracked history has 5 reports on CALX from 4 analyst firms in the last 90 days (9 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it, 1 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: JP Morgan lowered its target from $58.00 (set 22 Jul 2026) to $50.00 on 4 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Craig-Hallum | Christian D Schwab | Buy | 22 Jul 2026 | 62.00 USD |
| JPMorgan | Samik Chatterjee | Buy | 22 Jul 2026 | 58.00 USD |
| Needham | Ryan Koontz | Buy | 21 Jul 2026 | 62.00 USD |
| Northland Capital Markets | Tim Savageaux | Buy | 21 Jul 2026 | 52.00 USD |
| Rosenblatt | Mike Genovese | Buy | 21 Jul 2026 | 55.00 USD |
| Roth Capital | Scott Searle | Buy | 18 Jun 2026 | 85.00 USD |
| Weiss Ratings | Unnamed analyst | — | 26 Oct 2026 | — |
| Wolfe Research | George Notter | Hold | 1 Jul 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 18 Aug 2026 | 41.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 05:53 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.